Therapeutic Targets for Skin Cancer: MET Signaling and RAS Converge on EGFR

New findings from Science Signaling (21 Jun 2016: Vol. 9, Issue 433, pp. ra62 DOI: 10.1126/scisignal.aaf5106), this article indicates that EGFR pathway may offer potential therapeutic targets for patients. Here we provide part of this wonderful article. Read full details: http://stke.sciencemag.org/content/9/433/ra62. [table caption=”Related Products” width=”800″ colwidth=”100|250|180″ colalign=”left|center|center|center|center”] No.,Gene name,Product type,Product number 1,EGFR,Recombinant Protein,48 2,MET,Recombinant Protein,42 3,HGF,Recombinant Protein,30 4,HRAS,Recombinant Protein,19 [/table]   Introduction Studies using the multistage induction of squamous cancers on…

Read More >>